Psyence Biomedical Ltd.
13F holders, Q4 2024 (December 31)11holders
1famous investor
$2.04avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Psyence Biomedical Ltd. in their 13F filings. The largest holders were Hudson Bay Capital Management LP ($744K), Harraden Circle Investments, LLC ($385K) and Essential Planning, LLC. ($163K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F209
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $980K |
| Exits | 0 | $0 |
Ownership 11 holders
| Hudson Bay Capital Management LP | 0.01% | New | 380,000 | $744K |
| Harraden Circle Investments, LLC | 0.33% | — | 182,323 | $385K |
| Essential Planning, LLC. | 0.00% | New | 73,278 | $163K |
| AdvisorShares Investments LLC | 0.01% | Reduce -67.2% | 26,923 | $57K |
| HRT Financial LP | 0.00% | Add +1421.1% | 26,127 | $55K |
| Virtu Financial LLC | 0.00% | New | 12,692 | $27K |
| UBS Group AG | 0.00% | Add +1168.7% | 12,712 | $27K |
| Citadel Advisors | 0.00% | Add +1.8% | 11,490 | $24K |
| Scientech Research LLC | 0.01% | New | 11,183 | $24K |
| Connective Capital Management, LLC | 0.03% | New | 11,149 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -13.1% | 1,993 | $4K |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.